Newsgather

Food and Drug Administration

Steady13 stories7 sourcesLast updated: 1d ago

Latest Stories

Reposição de medicamentos: O que são e como salvam vidas
Developing
Health·1d agoAI summary

Reposição de medicamentos: O que são e como salvam vidas

O reposicionamento de medicamentos, que consiste em encontrar novos usos para fármacos já existentes, tem se mostrado uma estratégia eficaz e econômica para salvar vidas, especialmente em crises de saúde como a da COVID-19. Medicamentos como a dexametasona e o baricitinibe foram reaproveitados para tratar a inflamação em pacientes com coronavírus, salvando milhares de vidas. A Comissão Europeia planeja expandir essa abordagem para a busca de tratamentos contra o câncer. Exemplos históricos incluem o raloxifeno para prevenção de câncer de mama, a talidomida para mieloma múltiplo e o Viagra (sildenafil) para disfunção erétil, originalmente desenvolvido para doenças cardiovasculares. A tendência de reaproveitamento de medicamentos levanta questões sobre seus verdadeiros prós e contras, cujas respostas podem levar anos para serem totalmente compreendidas.

G
G1
Two US potato chip brands recalled amid salmonella concerns
NEWS
5/7/2026

Two US potato chip brands recalled amid salmonella concerns

Utz issues voluntary recall for certain varieties of Zapp’s and Dirty potato chips over contamination linked to seasoningSign up for the Breaking News US newsletter emailUtz has issued a voluntary US recall of two potato chip brands after concerns that they could be contaminated with salmonella, a type of bacteria that can lead to food-borne illness.Certain varieties of Zapp’s and Dirty potato chips may contain contamination linked to the seasoning used on the products, according to the US Food and Drug Administration in a recall issued on Monday. The recall applies to three flavors of Zapp’s chips sold in various bag sizes, along with three flavors of Dirty chips packaged in 2-ounce bags. Continue reading...

G
Guardian Business
US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive
NEWS
4/24/2026

US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive

The Food and Drug Administration said on Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest indication of the Trump administration’s commitment to the experimental treatment approach. President Donald Trump signed an executive order last weekend directing the FDA and other federal agencies to speed access and loosen restrictions on psychedelics, a class of hallucinogenic drugs which remain illegal...

S
SCMP Economy